Inhibikase Therapeutics, Inc. IKT
NASDAQ · United States · Health Technology
$2.00+0.07 (+3.63%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-11 | -0.11 | -0.11 | -2.3% | $0 | — | -2.4%$2.46→$2.40 |
| Q1 2026 | 2026-05-12 | -0.10 | -0.10 | 0.0% | — | — | -6.4%$2.03→$1.90 |
| Q4 2025 | 2026-03-26 | -0.09 | -0.12 | +25.0% | — | — | +3.1%$1.63→$1.68 |
| Q3 2025 | 2025-11-14 | -0.13 | -0.13 | 0.0% | — | — | -5.0%$1.60→$1.52 |
| Q1 2024 | 2024-05-15 | -0.73 | -0.79 | +7.6% | — | — | — |
| Q4 2023 | 2024-03-27 | -0.64 | -0.85 | +24.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.